| Product Code: ETC9979902 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) gRNA Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) gRNA Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) gRNA Market - Industry Life Cycle |
3.4 United States (US) gRNA Market - Porter's Five Forces |
3.5 United States (US) gRNA Market Revenues & Volume Share, By Product & Services, 2021 & 2031F |
3.6 United States (US) gRNA Market Revenues & Volume Share, By gRNA Type, 2021 & 2031F |
3.7 United States (US) gRNA Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) gRNA Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 United States (US) gRNA Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the health benefits of GRNA products |
4.2.2 Growing demand for natural and organic products in the US market |
4.2.3 Favorable government regulations supporting the GRNA market growth |
4.3 Market Restraints |
4.3.1 High production costs associated with GRNA products |
4.3.2 Limited availability of raw materials for GRNA products |
4.3.3 Intense competition from established brands in the US market |
5 United States (US) gRNA Market Trends |
6 United States (US) gRNA Market, By Types |
6.1 United States (US) gRNA Market, By Product & Services |
6.1.1 Overview and Analysis |
6.1.2 United States (US) gRNA Market Revenues & Volume, By Product & Services, 2021- 2031F |
6.1.3 United States (US) gRNA Market Revenues & Volume, By Products, 2021- 2031F |
6.1.4 United States (US) gRNA Market Revenues & Volume, By gRNA Final Products, 2021- 2031F |
6.1.5 United States (US) gRNA Market Revenues & Volume, By gRNA Synthesis Products, 2021- 2031F |
6.1.6 United States (US) gRNA Market Revenues & Volume, By gRNA Synthesis Kits, 2021- 2031F |
6.1.7 United States (US) gRNA Market Revenues & Volume, By Plasmids, 2021- 2031F |
6.1.8 United States (US) gRNA Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) gRNA Market, By gRNA Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) gRNA Market Revenues & Volume, By Research-Use, 2021- 2031F |
6.2.3 United States (US) gRNA Market Revenues & Volume, By GMP-grade, 2021- 2031F |
6.3 United States (US) gRNA Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) gRNA Market Revenues & Volume, By Genome Engineering, 2021- 2031F |
6.3.3 United States (US) gRNA Market Revenues & Volume, By Disease Model Studies, 2021- 2031F |
6.3.4 United States (US) gRNA Market Revenues & Volume, By Functional Genomics, 2021- 2031F |
6.3.5 United States (US) gRNA Market Revenues & Volume, By Epigenetics, 2021- 2031F |
6.3.6 United States (US) gRNA Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) gRNA Market, By End-Use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) gRNA Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 United States (US) gRNA Market Revenues & Volume, By Academic Research Institutes, 2021- 2031F |
6.4.4 United States (US) gRNA Market Revenues & Volume, By CMOs & CROs, 2021- 2031F |
7 United States (US) gRNA Market Import-Export Trade Statistics |
7.1 United States (US) gRNA Market Export to Major Countries |
7.2 United States (US) gRNA Market Imports from Major Countries |
8 United States (US) gRNA Market Key Performance Indicators |
8.1 Consumer engagement with GRNA products through social media interactions |
8.2 Number of new product launches in the GRNA market segment |
8.3 Growth in the number of retail outlets carrying GRNA products |
9 United States (US) gRNA Market - Opportunity Assessment |
9.1 United States (US) gRNA Market Opportunity Assessment, By Product & Services, 2021 & 2031F |
9.2 United States (US) gRNA Market Opportunity Assessment, By gRNA Type, 2021 & 2031F |
9.3 United States (US) gRNA Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) gRNA Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10 United States (US) gRNA Market - Competitive Landscape |
10.1 United States (US) gRNA Market Revenue Share, By Companies, 2024 |
10.2 United States (US) gRNA Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here